Pomerantz LLP

Company

Last mentioned: Mar 26, 2026

Timeline

  1. Lead Plaintiff Deadline

    Final date for investors to petition the court to lead the Enphase class action.

  2. Litigation Expansion

    Pomerantz confirms additional filings and alerts for Enphase and Nektar Therapeutics.

  3. Insider Sale

    Director Thurman Rodgers sells 137,250 shares of Enphase stock.

  4. Initial Filing

    Pomerantz LLP commences class action proceedings against Enphase Energy.

Stories mentioning Pomerantz LLP 2

About Pomerantz LLP coverage

This page surfaces every story mentioning Pomerantz LLP across our climate coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running climate beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Pomerantz LLP was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.